Diane Donegan is an Endocrinology/Metabolic physician affiliated with Mayo Clinic. OpenAlex indexes 96 publications with 1,084 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ascendis PharmaProgram year20243 paymentsResearch$25,406openpaymentsdata.cms.gov ↗
- Amryt Pharma HoldingsProgram year20234 paymentsResearch
- Recordati Rare DiseasesProgram year20234 paymentsResearch
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
41.3%l-Thyroxine30.4%Levothyroxine Sodium89%Synthroid11%Part D<11 patientsRecombinant Human Growth Hormone3.7%Genotropin63%Humatrope37%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
22.8%GLP-1 receptor agonist8.9%Ozempic62%Mounjaro38%Part D<11 patientsCorticosteroid4.9%Prednisone100%Part D≥11 patients+ 4 more classes in this area
Sensory organs
18.4%Corticosteroid18.4%Hydrocortisone91%Dexamethasone9%Part D≥39 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Management of Osilodrostat Therapy in Patients With Cushing's Syndrome: A Modified Delphi Consensus Panel
Journal of the Endocrine Society
2025 - Pituitary Photon-Counting Detector CT for Cushing Disease: Preoperative Lesion Localization, Intraoperative Findings, and Postoperative Outcomes
American Journal of Neuroradiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Bradley Boeve, MD
Mayo Clinic
S Rajkumar, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
Ayalew Tefferi, MD
Mayo Clinic
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”